Weng, J., Huang, A., Berake, T. B., Chen, S. L., Yan, B. M., & Karagozian, R. (2026). Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease. Gastroenterology Research, 19(3), 147-154. https://doi.org/10.14740/gr2136